EU Bans 20+ CMR Substances in Cosmetics Under New Regulation

Dr Steven Brennan
Dr Steven Brennan
2 min readAI-drafted, expert reviewed
Cosmetics

The European Commission has formally adopted Regulation (EU) 2025/877, banning the use of over 20 substances classified as carcinogenic, mutagenic, or toxic to reproduction (CMR) in cosmetic products. This amendment to Regulation (EC) No 1223/2009 will come into force on 1 September 2025, introducing significant implications for manufacturers, suppliers, and compliance officers across the chemicals and cosmetics value chain.

Key Insights

The regulation stems from classifications established in Commission Delegated Regulation (EU) 2024/197, which identified these substances as posing unacceptable risks to human health in consumer-facing products.

Key Substances and Their Industrial Uses

Among the banned substances is Trimethylbenzoyl Diphenylphosphine Oxide, previously permitted in professional-use nail systems for its photoinitiating properties. Also included are Tetrabromobisphenol-A and Bisphenol AF, commonly used for their stabilising and flame-retardant functions in packaging and formulation components.

The list extends to:

  • Pesticidal actives such as Clothianidin and Transfluthrin
  • Organotin compounds like Dibutyltin Maleate and Dibutyltin Oxide
  • Aromatic amines and isocyanates, including N,N-Dimethyl-p-toluidine and 3,3'-Dimethylbiphenyl-4,4'-diyl Diisocyanate
  • Several reaction mass mixtures involving bisphenol derivatives and fluorinated compounds

These substances are now listed in Annex II of Regulation (EC) No 1223/2009, prohibiting their use in any cosmetic formulation within the EU market.

Compliance Timeline and Sector Implications

The deadline for compliance is 1 September 2025, aligning with the application date of their CMR classifications. There have been no approved exceptions for continued use in cosmetic products.

This development demands immediate action from stakeholders, including:

  • Cosmetic formulators to review and reformulate products
  • Raw material suppliers to reassess portfolios
  • Retailers and importers to audit their supply chains

Non-compliance could result in product recalls, legal liabilities, and loss of EU market access.

Access the original source

Foresight continuously tracks 1000s of sources and maps updates to your portfolio:

  • Get alerted when changes affect your products or operations
  • Access source documents with full citations
  • Collaborate with your team on alerts and decisions

Related Articles

Join 3,500+ professionals staying ahead

Subscribe to Foresight Weekly and get the latest insights on regulatory changes affecting chemical compliance.

Free forever. Unsubscribe anytime.

Read by professionals at

Boeing
AstraZeneca
Siemens
PepsiCo
SpaceX